Peripheral artery disease (PAD) is a manifestation of systemic atherosclerosis. Modifiable
risk factors including cigarette smoking, dyslipidemia, diabetes, poor diet quality, obesity …

Cardiac Rehabilitation — Challenges, Advances, and the Road Ahead | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

Guideline Summary Chronic limb-threatening ischemia (CLTI) is associated with mortality,
amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are …

Background: The PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor
evolocumab reduced low-density lipoprotein cholesterol and cardiovascular events in the …

BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …

Background: Patients with acute coronary syndrome (ACS) and concomitant noncoronary
atherosclerosis have a high risk of major adverse cardiovascular events (MACEs) and …

Objective To assess low-density lipoprotein cholesterol (LDL-C) response in patients after
initiation of statins, and future risk of cardiovascular disease (CVD). Methods Prospective …

High-intensity statins are recommended for patients with peripheral artery disease (PAD).
Critical limb ischemia (CLI) is the most advanced presentation of PAD. The benefit of statins …

Background: Peripheral artery disease (PAD) affects more than 202 million people
worldwide. Several studies have shown that patients with PAD are often undertreated, and …

Diabetes mellitus is an important risk factor for the development of cardiovascular diseases.
Peripheral arterial disease affecting lower limb arteries is one of the clinical manifestations …